InterFinancial proudly supports David Hassum on initiative for breast cancer research

17.4.2019

We are proud to support Ride4Vee, an initiative to raise money for breast cancer research at the Queensland Institute of Medical Research in Australia.

The initiative is in honor of the memory of Veronica “Vee” Best, the companion of our colleague David Hassum. Vee was a remarkable woman, an avid traveller, and lover of life, nature, and animals. She died of breast cancer in 2018 at the age of 53.

In her memory David intends to cycle an 1,800 km stretch of the famous Great Divide Mountain Bike Route through the Rocky Mountains from Banff, Alberta to Jackson Hole, Wyoming. He will ride solo and expects to take between 32 and 35 days. This Ride4Vee can be supported with donations or pledges per kilometer completed.

All funds raised will go directly to the QIMR Berghofer Medical Research Institute, which is performing world-leading research into the detection and treatment of triple negative breast cancer, one of the most aggressive and least understood types of breast cancer. The research focuses on identifying a biomarker capable of accurately diagnosing aggressive breast cancers at a very early stage, and on developing strategies to best harness the immune system to eliminate cancer.

Donations can be made either as a lump sum or per kilometer achieved. All support is appreciated!

Click here for more information: http://www.4vee.net/ 

30.10.2024

Employee Q&A: Anuk Manchanda

We recently sat down for a chat with Anuk Manchanda, our talented M&A Director here at InterFinancial. With over 12 years of solid experience under his belt, Anuk shares what drives his passion for M&A, how he builds meaningful client relationships, and the key lessons he’s picked up along the way. With a background that […]

Read more
30.10.2024

China M&A market briefing as of October 2024

The Chinese economy is undoubtedly undergoing fundamental shifts due to a combination of factors, including slowed economic growth, ongoing political tensions with the West, a large aging population and changing demographics. Since the beginning of 2024, the capital market in China has witnessed several significant shifts in various industries and sectors.   Sluggish IPO market; […]

Read more
30.10.2024

Becoming Investor Ready is more than a stroke of luck

Imagine if you had access to a crystal ball 2 – 3 years before you raise capital or sell your business. What insights would you seek to make sure you’re getting the best possible valuation? This foresight, if it existed, would be invaluable. It will allow you plenty of time to make strategic improvements, strengthen […]

Read more
30.10.2024

Sector dashboards October 2024

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
29.9.2024

Sector dashboards September 2024

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
29.9.2024

Investing in Consumer Goods and Retail: is it time to go shopping?

It’s been a challenging few years for Consumer Goods and Retail companies. The pandemic, supply chain disruptions, rising interest rates and cost of living pressures have all had an impact on profits in the sector.   Of course, some companies did quite well during the pandemic. Think online shopping, home delivery meal boxes and camping […]

Read more
17.9.2024

From lab coat to deal sheet: celebrating Michael Kakanis’ journey to Director

We’re thrilled to announce the promotion of Michael Kakanis to Director at InterFinancial and his recent appointment as Co-Chair of Healthcare at Clairfield International.   Michael’s journey is nothing short of inspiring. Working as a lecturer in Physiology and Biochemistry while completing his PhD in Immunology, Michael was all set for a long career in Academia. […]

Read more
03.9.2024

7 key challenges to overcome when investing in Australian renewable energy

Properly understanding the potential financial returns of an investment in the context of operations in the Australian Energy market  Renewable energy generation projects utilising solar, wind and battery technology find revenue sources from offtake agreements, arbitrage of wholesale electricity prices, providing grid stabilization services via mechanisms such as FCAS and by accessing green trading certificates […]

Read more
27.8.2024

Employee Q&A: Nasia Christodoulou

At InterFinancial, our strength lies in the passion and expertise of our talented team. Today, we’re shining the spotlight on Nasia Christodoulou, who joined us as a Research Assistant in January 2023 and has since progressed to Analyst. In this Q&A, Nasia gives us a glimpse into her daily routine, the challenges she overcomes, and […]

Read more